2026. SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF ABEMACICLIB IN THE TREATMENT OF HR+/HER2− ADVANCED OR METASTATIC BREAST CANCER . Vietnam Journal of Community Medicine. 67, 10 (Nov. 2026). DOI:https://doi.org/10.52163/yhc.v67i10.6967.